Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Italy Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20092
20102
20114
20122
20132
20155
20165
20175
20193
20205
20219
20226
20238
20249
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated19
Active, not recruiting17
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Eli Lilly and Company7
GlaxoSmithKline4
AstraZeneca3
Exelixis3
Incyte Corporation3
Seagen Inc.3
Amgen2
Bayer2
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung71
Colorectal Neoplasms22
Triple Negative Breast Neoplasms14
Melanoma13
Neoplasms12
Carcinoma, Renal Cell10
Lung Neoplasms10
Neoplasm Metastasis10
Squamous Cell Carcinoma of Head and Neck10
Stomach Neoplasms10

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.